Angiotensin II-aldosterone interactions on protein synthesis in vascular smooth muscle cellsULLIAN, M. E; HUTCHISON, F. N; HAZEN-MARTIN, D. J et al.American journal of physiology. Cell physiology. 1993, Vol 33, Num 6, pp C1525-C1531, issn 0363-6143Article

Novel synthesis and biochemical properties of an [¹²⁵I]-labeled photoaffinity probe for thromboxane A₂/prostaglandin H₂ receptorsMAIS, D. E; BOWLING, N. L; TRUE, T. A et al.Journal of medicinal chemistry (Print). 1991, Vol 34, Num 4, pp 1511-1514, issn 0022-2623, 4 p.Article

Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cellsVELARDE, V; ULLIAN, M. E; MORINELLI, T. A et al.American journal of physiology. Cell physiology. 1999, Vol 46, Num 2, pp C253-C261, issn 0363-6143Article

Synthesis of 10,10-difluorothromboxane A₂, a potent and chemically stable thromboxane agonistFRIED, J; JOHN, V; SZWEDO, M. J. JR et al.Journal of the American Chemical Society. 1989, Vol 111, Num 12, pp 4510-4511, issn 0002-7863Article

Radioimmunoassay of human platelet thrombospondin: different patterns of thrombospondin and β-thromboglobulin antigen secretion and clearance from the circulationSWITALSKA, H. I; NIEWIAROWSKI, S; TUSZYNSKI, G. P et al.The Journal of laboratory and clinical medicine. 1985, Vol 106, Num 6, pp 690-700, issn 0022-2143Article

Thromboxane A₂/prostaglandin H₂ receptors in streptozotocin-induced diabetes : effects of insulin therapy in the ratMORINELLI, T. A; TEMPEL, G. E; JAFFA, A. A et al.Prostaglandins. 1993, Vol 45, Num 5, pp 427-438, issn 0090-6980Article

Differential effect of pH on thromboxane A₂/prostaglandin H₂ receptor agonist and antagonist binding in human plateletsMAYEUX, P. R; MORINELLI, T. A; WILLIAMS, T. C et al.The Journal of biological chemistry (Print). 1991, Vol 266, Num 21, pp 13752-13758, issn 0021-9258, 7 p.Article

Difluorothromboxane A₂ and stereoisomers: stable derivatives of thromboxane A₂ with differential effects on platelets and blood vesselsMORINELLI, T. A; OKWU, A. K; MAIS, D. E et al.Proceedings of the National Academy of Sciences of the United States of America. 1989, Vol 86, Num 14, pp 5600-5604, issn 0027-8424Article

Receptor-mediated effects of a PGH₂ analogue (U 46619) on human plateletsMORINELLI, T. A; NIEWIAROWSKI, S; DANIEL, J. L et al.American journal of physiology. Heart and circulatory physiology. 1987, Vol 22, Num 5, pp H1035-H1043, issn 0363-6135Article

Tyrosine phosphorylation of phosphatidylinositol 3-kinase and of the thromboxane A₂ (TXA₂) receptor by the TXA₂ mimetic I-BOP in A7r5 cellsMORINELLI, T. A; FINLEY, E. L; JAFFA, A. A et al.Biochemical pharmacology. 1997, Vol 53, Num 12, pp 1823-1832, issn 0006-2952Article

Thromboxane A₂/prostaglandin H₂-stimulated mitogenesis of coronary artery smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinaseMORINELLI, T. A; LI-MING ZHANG; NEWMAN, W. H et al.The Journal of biological chemistry (Print). 1994, Vol 269, Num 8, pp 5693-5698, issn 0021-9258Article

7-[1R,2S,3S,5R-6,6-dimethyl-3-(4-lodobenzenesulfonylamino)bicyclo[3.1.1]Hept-2-yl]-5(Z)-heptenoic acid : a novel high-affinity radiolabeled antagonist for platelet thromboxane A₂/prostaglandin H₂ receptorsNAKA, M; MAIS, D. E; MORINELLI, T. A et al.The Journal of pharmacology and experimental therapeutics. 1992, Vol 262, Num 2, pp 632-637, issn 0022-3565Article

Separation of different receptor-mediated effects of a prostaglandin H₂ analogue (U46619) on human platelets by means of human granulocytic elastase and chymotrypsinLUKASIEWICZ, H; MAN-LING PENG; MORINELLI, T. A et al.Biochemical pharmacology. 1989, Vol 38, Num 19, pp 3213-3217, issn 0006-2952Article

Membrane fluidity and platelet fibrinogen receptor exposure by proteolytic enzymesSIMONS, E; WHITIN, J. C; MORINELLI, T. A et al.Thrombosis research. 1985, Vol 39, Num 1, pp 91-96, issn 0049-3848Article